These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 7442137)

  • 1. Gas-chromatographic method for the halothane metabolites, trifluoroacetic acid and bromide, in biological fluids.
    Maiorino RM; Gandolfi AJ; Sipes IG
    J Anal Toxicol; 1980; 4(5):250-4. PubMed ID: 7442137
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The gas chromatographic mass spectrometric determination of trifluoroacetic acid in biological fluid. Application to halothane metabolism.
    Karashima D; Takahashi S; Shigematsu A; Furukawa T; Kuhara T
    Biomed Mass Spectrom; 1976 Feb; 3(1):41-4. PubMed ID: 4173
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative analysis of trifluoroacetic acid in body fluids of patients treated with halothane.
    Witte L; Nau H; Fuhrhop JH; Doenicke A; Grote B
    J Chromatogr; 1977 Jul; 143(4):329-34. PubMed ID: 885973
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A gas chromatographic mass spectrometric method for the analysis of trifluoroacetic acid: application to the metabolism of halothane by in vitro preparations.
    Gruenke LD; Waskell LA
    Biomed Environ Mass Spectrom; 1988 Dec; 17(6):471-5. PubMed ID: 3240374
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determination of the halothane metabolites trifluoroacetic acid and bromide in plasma and urine by ion chromatography.
    Hankins DC; Kharasch ED
    J Chromatogr B Biomed Sci Appl; 1997 May; 692(2):413-8. PubMed ID: 9188831
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Esterification of trifluoroacetic acid with phenyldiazomethane for quantitative gas chromatographic analysis. Methods involving separation from biological materials.
    Karashima D; Shigematsu A; Furukawa T
    J Chromatogr; 1977 Jan; 130():77-86. PubMed ID: 853094
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of halothane oxidation by hepatic microsomes and purified cytochromes P-450 using a gas chromatographic mass spectrometric assay.
    Gruenke LD; Konopka K; Koop DR; Waskell LA
    J Pharmacol Exp Ther; 1988 Aug; 246(2):454-9. PubMed ID: 3404442
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolism of halothane in obese Fischer 344 rats.
    Biermann JS; Rice SA; Fish KJ; Serra MT
    Anesthesiology; 1989 Sep; 71(3):431-7. PubMed ID: 2774271
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative analysis of volatile halothane metabolites in biological tissues by gas chromatography.
    Maiorino RM; Sipes IG; Gandolfi AJ; Brown BR
    J Chromatogr; 1979 Sep; 164(1):63-72. PubMed ID: 541398
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Halothane metabolism in cirrhotic rats.
    Baden JM; Serra M; Fujinaga M; Mazze RI
    Anesthesiology; 1987 Nov; 67(5):660-4. PubMed ID: 3674465
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of disulfiram, diethyldithiocarbamate and carbon disulfide on the metabolic formation of trifluoroacetic acid from halothane in the rat.
    Eckes L; Büch HP
    Arzneimittelforschung; 1985; 35(9):1447-51. PubMed ID: 3002400
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biliary excretion of the halothane metabolite trifluoroacetic acid in infants.
    Wark H; Earl J; Chau D; Overton J
    Anaesth Intensive Care; 1991 May; 19(2):213-6. PubMed ID: 2069241
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of exposure concentrations on distribution of halothane metabolites in the body.
    Fiserova-Bergerova V; Kawiecki RW
    Drug Metab Dispos; 1984; 12(1):98-105. PubMed ID: 6141921
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The interaction of enflurane, halothane and the halothane metabolite trifluoroacetic acid with the binding of acidic drugs to human serum albumin. An in vitro study.
    Dale O
    Biochem Pharmacol; 1986 Feb; 35(4):557-61. PubMed ID: 3947389
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimum conditions for formation of aflatoxin M1-trifluoroacetic acid derivative.
    Stubblefield RD
    J Assoc Off Anal Chem; 1987; 70(6):1047-9. PubMed ID: 3125145
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TRIFLUOROACETIC ACID AS METABOLITE OF HALOTHANE.
    STIER A
    Biochem Pharmacol; 1964 Nov; 13():1544. PubMed ID: 14239633
    [No Abstract]   [Full Text] [Related]  

  • 17. Distribution of halothane and the metabolites trifluoroacetic acid and bromide in the conceptus after halothane inhalation by pregnant mice.
    Ghantous H; Parnerud I; Danielsson BR; Dencker L
    Acta Pharmacol Toxicol (Copenh); 1986 Nov; 59(5):370-6. PubMed ID: 3811965
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analytical isotachophoresis utilizing computer simulation. II. Assessment of optimum separation conditions for urinary trifluoroacetic acid metabolized from anaesthetic halothane.
    Hirokawa T; Takemi H; Kiso Y; Takiyama R; Morio M; Fujii K; Kikuchi H
    J Chromatogr; 1984 Feb; 305(2):429-37. PubMed ID: 6707170
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determination of urochloralic acid, the glucuronic acid conjugate of trichloroethanol, by gas chromatography with electron-capture detection and its application to urine, plasma and liver.
    Ikeda M; Hattori H; Koyama Y; Ohmori S
    J Chromatogr; 1984 Apr; 307(1):111-9. PubMed ID: 6725477
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Halothane biotransformation in obese and nonobese patients.
    Bentley JB; Vaughan RW; Gandolfi AJ; Cork RC
    Anesthesiology; 1982 Aug; 57(2):94-7. PubMed ID: 7091749
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.